Skip to main content

UCP Professional Learning Series: Management​ of​ Difficult Clinical Presentations of Hypertonia​ in ​Children with Disabilities​

Thursday, June 2, 2022 | 5-6:30pm CST

Learning Objectives:

At the end of the session, attendees should be able to:

  • Analyze difficult hypertonic and complex movement disorders and possible treatment options, including the importance of a team approach in patient management. 
  • Determine when a deep brain stimulator can be useful in managing severe dystonic and dyskinetic conditions. 
  • Distinguish which patients may be successfully treated with a ventral-dorsal rhizotomy or a selective dorsal rhizotomy. 
  • Evaluate when intrathecal baclofen, phenol neurolysis, and botulinum toxin injections may be useful in treating hypertonic conditions. 

Gillette Children’s Accreditation Statement:

Continuing Medical Education (CME) Information:

Credit Designation: 1.5 AMA PRA Category 1 Credits™ | 1.5 Contact/Clock Hours

Physicians/APPs: Gillette Children’s is accredited by the Minnesota Medical Association (MMA) to provide continuing medical education (CME) for physicians and takes responsibility for the content, quality, and integrity of this educational activity. Gillette Children’s designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.  Physicians/APPs should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses: This activity is designed to meet the Minnesota Board of Nursing (MNBON) continuing education requirements for 1.5 contact hours. It is the participant’s responsibility to ascertain if this activity meets the mandatory continuing education requirements of the licensing board under which they practice.

Others: This activity is worth a maximum of 1.5 clock hours. It is the responsibility of the individual to determine if this activity meets their professional requirements for continuing education credit.

Disclosure Statement: It is the policy of Gillette Children’s, in accordance with the Minnesota Medical Association (MMA), to ensure balance, independence, objectivity, and scientific rigor in all CME activities. Dr. Mark Gormley provides research support for Allergan (AbbVie) and Ipsen Biopharmaceuticals. Dr. Mark Gormley’s relevant financial relationships have been fully mitigated and no other planners of this educational activity have any relevant financial relationships with ineligible companies to disclose.

Questions: If you have any questions regarding this CME activity, please contact us at